drugset / Trial / NCT00413335

Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth

NCT00413335

Completed 21 enrolled Yale University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of the study is to determine whether treatment of children and adolescents with Impaired Glucose Tolerance (IGT) with rosiglitazone will lead to improvements in insulin sensitivity and glucose tolerance.

Timeline

Start
2005-11
Primary completion
2008-09
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rosiglitazone Small molecule 4 mg